Nectar Lifesciences announces audited financial results, board meeting outcome

Nectar Lifesciences today announced its audited financial results and the outcome of its Board of Directors meeting held on July 7, 2025. The board approved standalone and consolidated financial results for the quarter and year ended March 31, 2025, as reviewed by Audit Committee on July 7, 2025 and further Audited by the Statutory Auditors of the Company.